All News AbbVie Inc.

Equities

ABBV

US00287Y1091

Real-time Estimate Cboe BZX Other stock markets 02:45:38 2024-06-11 pm EDT			5-day change	1st Jan Change
168.2 ^USD	-1.31%		+3.82%	+8.62%

11:27am	Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar	MT
Jun. 10	Three companies to bet on medical AI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients	08:01am	PR
Alvotech Expands Alliance with STADA to Include Denosumab Biosimilar	05:27am	MT
Three companies to bet on medical AI	Jun. 10
Global markets live: ABB, Roche, Microsoft, Apple, Tesla...	Jun. 10
AbbVie's Blood Cancer Treatment Receives Scottish Approval	Jun. 10	MT
Top law firms in US opioid lawsuits to get hundreds of millions in fees	Jun. 07	RE
AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers	Jun. 07	AQ
AbbVie - SkinMedica Celebrates 25 Years of Empowering Radiant Skin	Jun. 07	AQ
AbbVie's tight grip on Humira market raises concerns about biosimilars	Jun. 07	RE
AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint	Jun. 06	MT
AbbVie's ovarian cancer therapy succeeds in mid-stage trial	Jun. 06	RE
AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing Platinum-Sensitive Ovarian Cancer	Jun. 06	PR
AbbVie Inc. Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer	Jun. 06	CI
SkinMedica® Celebrates 25 Years of Empowering Radiant Skin	Jun. 06	PR
Global markets live: Inditex, Intel, TSMC, Dollar Tree, AbbVie...	Jun. 05
AbbVie Says First Patient Treated in Phase 3 Trial Assessing Potential Blood Cancer Treatment	Jun. 05	MT
The odds of rates getting cut in 2024 may be better than you think	Jun. 05
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383	Jun. 05	PR
AbbVie Advances Oncology Pipeline with Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383	Jun. 05	CI
HSBC Upgrades AbbVie to Buy From Hold, Adjusts Price Target to $185 From $161	Jun. 05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News AbbVie Inc.

Equities

ABBV

US00287Y1091

All News

Filters